Xiidra (lifitegrast ) Professional Sample recalls
The FDA has published 1 recall involving Xiidra (lifitegrast ) Professional Sample since 2022. The latest was reported on 15 Jun 2022. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why xiidra (lifitegrast ) professional sample is recalled
Companies
By year
All xiidra (lifitegrast ) professional sample recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Xiidra (lifitegrast ophthalmic solution) 5% Professional Sample recalled | Novartis Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Xiidra (lifitegrast ) Professional Sample?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.